{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T13:09:40Z","timestamp":1763989780236,"version":"3.45.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T00:00:00Z","timestamp":1763942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research, UK","doi-asserted-by":"crossref","award":["03122020"],"award-info":[{"award-number":["03122020"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Altered thyroid function (TF), especially non\n                    <jats:bold>-<\/jats:bold>\n                    thyroidal illness syndrome (NTIS), is common in hospitalised COVID\n                    <jats:bold>-<\/jats:bold>\n                    19 patients, but adaptive responses to disease as captured by blood biomarkers in the context of thyroid signal integration require further elucidation. This retrospective study analysed 29 routine biomarkers, including immune, inflammatory, haematological, organ damage, and TF markers, from patients admitted to the University Hospital Coventry and Warwickshire, decoding associations of the biomarkers with TF key determinants and identifying patterns of severity\n                    <jats:bold>-<\/jats:bold>\n                    specific thyroid dysfunction. Patients were categorised by disease severity based on admission to either critical care units (CCU) or general wards. Among 237 records, 140 were CCU admissions (mean age 57, 69% male) and 97 were general ward patients (mean age 63, 59% male). Both groups exhibited negative correlations between haematology and TF biomarkers with inflammation and organ dysfunction markers. The pattern of clustering and the deduced network built around the correlation of TF components also exhibited disease severity\n                    <jats:bold>-<\/jats:bold>\n                    specific characteristics. At least 11 biomarkers, including free\n                    <jats:bold>-<\/jats:bold>\n                    triiodothyronine (fT3) and free\n                    <jats:bold>-<\/jats:bold>\n                    thyroxine (fT4), showed significant group\n                    <jats:bold>-<\/jats:bold>\n                    specific differences. Notably, CCU patients demonstrated an interleukin\n                    <jats:bold>-<\/jats:bold>\n                    6\n                    <jats:bold>-<\/jats:bold>\n                    dependent enhancement of correlations between TSH and fT3 or the fT3\/fT4 ratio. Our findings suggest an immune-driven adaptation of the pituitary-thyroid axis, often presenting as NTIS in COVID-19. Deciphering information from routine biomarkers could enhance TF assessment, particularly in critically ill patients.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-25434-1","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T12:30:34Z","timestamp":1763987434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dissecting biomarker networks linking COVID-19 inflammatory drivers, disease severity and thyroid adaptive responses"],"prefix":"10.1038","volume":"15","author":[{"given":"Assem","family":"Aimaganova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Khovanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Braybrook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Vryonis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil R.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris K.","family":"Grammatopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,24]]},"reference":[{"key":"25434_CR1","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","volume":"26","author":"A Gupta","year":"2020","unstructured":"Gupta, A. et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 26, 1017\u20131032 (2020).","journal-title":"Nat. Med."},{"key":"25434_CR2","doi-asserted-by":"publisher","first-page":"bqab203","DOI":"10.1210\/endocr\/bqab203","volume":"163","author":"SA Clarke","year":"2022","unstructured":"Clarke, S. A., Abbara, A. & Dhillo, W. S. Impact of COVID-19 on the endocrine system: A mini-review. Endocrinology 163, bqab203 (2022).","journal-title":"Endocrinology"},{"key":"25434_CR3","doi-asserted-by":"publisher","first-page":"bqaa108","DOI":"10.1210\/endocr\/bqaa108","volume":"161","author":"E Lazartigues","year":"2020","unstructured":"Lazartigues, E., Qadir, M. M. F. & Mauvais-Jarvis, F. Endocrine significance of SARS-CoV-2\u2019s reliance on ACE2. Endocrinology 161, bqaa108 (2020).","journal-title":"Endocrinology"},{"key":"25434_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/thy.2022.0229","volume":"33","author":"VF Koehler","year":"2023","unstructured":"Koehler, V. F. et al. Thyroidal angiotensin-converting enzyme 2 protein expression and thyroid function tests in patients with COVID-19: Results from a retrospective case series and a prospective cohort study. Thyroid 33, 177\u2013185 (2023).","journal-title":"Thyroid"},{"key":"25434_CR5","doi-asserted-by":"publisher","first-page":"1477389","DOI":"10.3389\/fendo.2024.1477389","volume":"15","author":"A Panesar","year":"2024","unstructured":"Panesar, A., Gharanei, P., Khovanova, N., Young, L. & Grammatopoulos, D. Thyroid function during COVID-19 and post-COVID complications in adults: A systematic review. Front. Endocrinol. 15, 1477389 (2024).","journal-title":"Front. Endocrinol."},{"key":"25434_CR6","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41574-023-00946-w","volume":"20","author":"DTW Lui","year":"2024","unstructured":"Lui, D. T. W., Lee, C. H., Woo, Y. C., Hung, I. F. N. & Lam, K. S. L. Thyroid dysfunction in COVID-19. Nat. Rev. Endocrinol. 20, 336\u2013348 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"key":"25434_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3389\/fendo.2017.00163","volume":"8","author":"A Chatzitomaris","year":"2017","unstructured":"Chatzitomaris, A. et al. Thyroid Allostasis-adaptive responses of thyrotropic feedback control to conditions of strain, stress, and developmental programming. Front. Endocrinol. 8, 163 (2017).","journal-title":"Front. Endocrinol."},{"key":"25434_CR8","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1089\/thy.2014.0201","volume":"24","author":"G Van Den Berghe","year":"2014","unstructured":"Van Den Berghe, G. Non-thyroidal illness in the ICU: A syndrome with different faces. Thyroid 24, 1456\u20131465 (2014).","journal-title":"Thyroid"},{"key":"25434_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/cen.14476","volume":"95","author":"DTW Lui","year":"2021","unstructured":"Lui, D. T. W. et al. Role of non-thyroidal illness syndrome in predicting adverse outcomes in COVID-19 patients predominantly of mild-to-moderate severity. Clin. Endocrinol. (Oxf) 95, 469\u2013477 (2021).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"25434_CR10","doi-asserted-by":"publisher","first-page":"E926","DOI":"10.1210\/clinem\/dgaa813","volume":"106","author":"DTW Lui","year":"2021","unstructured":"Lui, D. T. W. et al. Thyroid dysfunction in relation to immune profile, disease status, and outcome in 191 patients with COVID-19. J. Clin. Endocrinol. Metab. 106, E926\u2013E935 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"25434_CR11","doi-asserted-by":"publisher","first-page":"1322487","DOI":"10.3389\/fendo.2024.1322487","volume":"15","author":"O Sror-Turkel","year":"2024","unstructured":"Sror-Turkel, O., El-Khatib, N., Sharabi-Nov, A., Avraham, Y. & Merchavy, S. Low TSH and low T3 hormone levels as a prognostic for mortality in COVID-19 intensive care patients. Front. Endocrinol. 15, 1322487 (2024).","journal-title":"Front. Endocrinol."},{"key":"25434_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1089\/thy.2020.0363","volume":"31","author":"M Chen","year":"2021","unstructured":"Chen, M., Zhou, W. & Xu, W. Thyroid function analysis in 50 patients with COVID-19: A retrospective study. Thyroid 31, 8\u201311 (2021).","journal-title":"Thyroid"},{"key":"25434_CR13","doi-asserted-by":"publisher","first-page":"850328","DOI":"10.3389\/fendo.2022.850328","volume":"13","author":"S Sciacchitano","year":"2022","unstructured":"Sciacchitano, S. et al. Nonthyroidal illness syndrome: To Treat or not to treat? Have we answered the question? A Review of Metanalyses. Front. Endocrinol. 13, 850328 (2022).","journal-title":"Front. Endocrinol."},{"key":"25434_CR14","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-8587(15)00225-9","volume":"3","author":"E Fliers","year":"2015","unstructured":"Fliers, E., Bianco, A. C., Langouche, L. & Boelen, A. Thyroid function in critically ill patients. Lancet Diabetes Endocrinol. 3, 816\u2013825 (2015).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"25434_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccc.2005.10.001","volume":"22","author":"LJ De Groot","year":"2006","unstructured":"De Groot, L. J. Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit. Care Clin. 22, 57\u201386 (2006).","journal-title":"Crit. Care Clin."},{"key":"25434_CR16","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s40618-020-01482-4","volume":"44","author":"E Fliers","year":"2021","unstructured":"Fliers, E. & Boelen, A. An update on non-thyroidal illness syndrome. J. Endocrinol. Invest. 44, 1597\u20131607 (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"25434_CR17","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1172\/JCI44678","volume":"121","author":"SM Wajner","year":"2011","unstructured":"Wajner, S. M., Goemann, I. M., Bueno, A. L., Larsen, P. R. & Maia, A. L. IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells. J. Clin. Invest. 121, 1834\u20131845 (2011).","journal-title":"J. Clin. Invest."},{"key":"25434_CR18","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s40618-021-01506-7","volume":"44","author":"L Croce","year":"2021","unstructured":"Croce, L. et al. The cytokine storm and thyroid hormone changes in COVID-19. J. Endocrinol. Invest. 44, 891\u2013904 (2021).","journal-title":"J. Endocrinol. Invest."},{"key":"25434_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12902-021-00896-2","volume":"21","author":"J Zheng","year":"2021","unstructured":"Zheng, J. et al. Suppression of the hypothalamic-pituitary-thyroid axis is associated with the severity of prognosis in hospitalized patients with COVID-19. BMC Endocr. Disord. 21, 228 (2021).","journal-title":"BMC Endocr. Disord."},{"key":"25434_CR20","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1089\/thy.2021.0225","volume":"31","author":"FEDL Beltr\u00e3o","year":"2021","unstructured":"Beltr\u00e3o, F. E. D. L. et al. Thyroid hormone levels during hospital admission inform disease severity and mortality in COVID-19 patients. Thyroid 31, 1639\u20131649 (2021).","journal-title":"Thyroid"},{"key":"25434_CR21","doi-asserted-by":"crossref","unstructured":"Dhar, S.K., Vishnupriyan, K., Damodar, S., Gujar, S. and Das, M. IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression. Heliyon 7, (2021).","DOI":"10.1101\/2020.08.15.20175844"},{"key":"25434_CR22","unstructured":"The Royal College of Pathologists. Guidance on the use and interpretation of clinical biochemistry tests in patients with COVID-19 infection (2020). https:\/\/www.rcpath.org\/static\/3f1048e5-22ea-4bda-953af20671771524\/43ac7e9b-e13f-4935-a20ba6966e0d5a18\/G217-RCPath-guidance-on-use-and-interpretation-of-clinical-biochemistry-tests-in-patients-with-COVID-19-infection.pdf#:~:text=This%20document%20outlines%20the%20biochemical%20tests%20that%20have"},{"key":"25434_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/00045632211014244","volume":"59","author":"RS Loomba","year":"2022","unstructured":"Loomba, R. S. et al. Serum biomarkers for prediction of mortality in patients with COVID-19. Ann. Clin. Biochem. 59, 15\u201322 (2022).","journal-title":"Ann. Clin. Biochem."},{"key":"25434_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/emermed-2020-210081","volume":"39","author":"G Turcato","year":"2022","unstructured":"Turcato, G. et al. Severity of SARS-CoV-2 infection and albumin levels recorded at the first emergency department evaluation: A multicentre retrospective observational study. Emerg. Med. J. 39, 63\u201369 (2022).","journal-title":"Emerg. Med. J."},{"key":"25434_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000447967","volume":"5","author":"R Hoermann","year":"2016","unstructured":"Hoermann, R., Midgley, J. E. M., Larisch, R. & Dietrich, J. W. Relational stability of thyroid hormones in euthyroid subjects and patients with autoimmune thyroid disease. Eur. Thyroid J. 5, 171\u2013179 (2016).","journal-title":"Eur. Thyroid J."},{"key":"25434_CR26","first-page":"1695","volume":"77","author":"A Boelen","year":"1993","unstructured":"Boelen, A., Platvoet-Ter Schiphorst, M. C. & Wiersinga, W. M. Association between serum interleukin-6 and serum 3,5,3\u2019-triiodothyronine in nonthyroidal illness. J. Clin. Endocrinol. Metab. 77, 1695\u20131699 (1993).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"25434_CR27","doi-asserted-by":"publisher","first-page":"1041676","DOI":"10.3389\/fendo.2022.1041676","volume":"13","author":"CL Rossetti","year":"2022","unstructured":"Rossetti, C. L. et al. COVID-19 and thyroid function: What do we know so far?. Front. Endocrinol. 13, 1041676 (2022).","journal-title":"Front. Endocrinol."},{"key":"25434_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1530\/EJE-20-0335","volume":"183","author":"A Lania","year":"2020","unstructured":"Lania, A. et al. Thyrotoxicosis in patients with COVID-19: The THYRCOV study. Eur. J. Endocrinol. 183, 381\u2013387 (2020).","journal-title":"Eur. J. Endocrinol."},{"key":"25434_CR29","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2213-8587(20)30266-7","volume":"8","author":"I Muller","year":"2020","unstructured":"Muller, I. et al. SARS-CoV-2-related atypical thyroiditis. Lancet Diabetes Endocrinol. 8, 739\u2013741 (2020).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"25434_CR30","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","volume":"26","author":"DM Del Valle","year":"2020","unstructured":"Del Valle, D. M. et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med. 26, 1636\u20131643 (2020).","journal-title":"Nat. Med."},{"key":"25434_CR31","unstructured":"de Bruin, S. et al. Clinical features and prognostic factors in Covid-19: A prospective cohort study. EBioMedicine 67, (2021)."},{"key":"25434_CR32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.7861\/clinmed.2020-0424","volume":"20","author":"AS Bannaga","year":"2020","unstructured":"Bannaga, A. S. et al. C-reactive protein and albumin association with mortality of hospitalised SARS-CoV-2 patients: A tertiary hospital experience. Clin. Med. 20, 463\u2013467 (2020).","journal-title":"Clin. Med."},{"key":"25434_CR33","doi-asserted-by":"crossref","unstructured":"Ghanem, M., Brown, S. J., EAT Mohamed, A. & Fuller, H. R. A meta-summary and bioinformatic analysis identified interleukin 6 as a master regulator of COVID-19 severity biomarkers. Cytokine 159, (2022).","DOI":"10.1016\/j.cyto.2022.156011"},{"key":"25434_CR34","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1210\/clinem\/dgab148","volume":"106","author":"I Grondman","year":"2021","unstructured":"Grondman, I. et al. The association of TSH and thyroid hormones with lymphopenia in bacterial sepsis and COVID-19. J. Clin. Endocrinol. Metab. 106, 1994\u20132009 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"25434_CR35","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cyto.2016.03.004","volume":"81","author":"\u00c1 Quispe","year":"2016","unstructured":"Quispe, \u00c1., Li, X. M. & Yi, H. Comparison and relationship of thyroid hormones, IL-6, IL-10 and albumin as mortality predictors in case-mix critically ill patients. Cytokine 81, 94\u2013100 (2016).","journal-title":"Cytokine"},{"key":"25434_CR36","doi-asserted-by":"publisher","first-page":"E4047","DOI":"10.1093\/cid\/ciaa1091","volume":"73","author":"PN Perez-Guzman","year":"2021","unstructured":"Perez-Guzman, P. N. et al. Clinical characteristics and predictors of outcomes of hospitalized patients with coronavirus disease 2019 in a multiethnic london national health service trust: A retrospective cohort study. Clin. Infect. Dis. 73, E4047\u2013E4057 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"25434_CR37","doi-asserted-by":"publisher","first-page":"E803","DOI":"10.1210\/clinem\/dgaa830","volume":"106","author":"B Khoo","year":"2021","unstructured":"Khoo, B. et al. Thyroid function before, during, and after COVID-19. J. Clin. Endocrinol. Metab. 106, E803\u2013E811 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"25434_CR38","doi-asserted-by":"publisher","first-page":"R67","DOI":"10.1530\/JOE-15-0133","volume":"225","author":"EM de Vries","year":"2015","unstructured":"de Vries, E. M., Fliers, E. & Boelen, A. The molecular basis of the non-thyroidal illness syndrome. J. Endocrinol. 225, R67\u2013R81 (2015).","journal-title":"J. Endocrinol."},{"key":"25434_CR39","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.3390\/nu15224790","volume":"15","author":"V Garofalo","year":"2023","unstructured":"Garofalo, V. et al. Relationship between iron deficiency and thyroid function: A systematic review and meta-analysis. Nutrients 15, 4790 (2023).","journal-title":"Nutrients"},{"key":"25434_CR40","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1210\/jc.2012-4223","volume":"98","author":"NC Hadlow","year":"2013","unstructured":"Hadlow, N. C. et al. The relationship between TSH and free T\u2084 in a large population is complex and nonlinear and differs by age and sex. J. Clin. Endocrinol. Metab. 98, 2936\u20132943 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"25434_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1530\/EJE-16-0007","volume":"175","author":"D Strich","year":"2016","unstructured":"Strich, D., Karavani, G., Edri, S. & Gillis, D. TSH enhancement of FT4 to FT3 conversion is age dependent. Eur. J. Endocrinol. 175, 49\u201354 (2016).","journal-title":"Eur. J. Endocrinol."},{"key":"25434_CR42","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fendo.2018.00091","volume":"9","author":"J Berberich","year":"2018","unstructured":"Berberich, J., Dietrich, J. W., Hoermann, R. & M\u00fcller, M. A. Mathematical modeling of the pituitary-thyroid feedback loop: Role of a TSH-T3-shunt and sensitivity analysis. Front. Endocrinol. 9, 91 (2018).","journal-title":"Front. Endocrinol."},{"key":"25434_CR43","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1515\/cclm-2021-0805","volume":"59","author":"M Llamas","year":"2021","unstructured":"Llamas, M., Garo, M. L. & Giovanella, L. Low free-T3 serum levels and prognosis of COVID-19: Systematic review and meta-analysis. Clin. Chem. Lab. Med. 59, 1906\u20131913 (2021).","journal-title":"Clin. Chem. Lab. Med."},{"key":"25434_CR44","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1089\/thy.2016.0133","volume":"26","author":"L Chaker","year":"2016","unstructured":"Chaker, L. et al. Thyroid function characteristics and determinants: The rotterdam study. Thyroid 26, 1195\u20131204 (2016).","journal-title":"Thyroid"},{"key":"25434_CR45","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/cen.13107","volume":"85","author":"SJ Brown","year":"2016","unstructured":"Brown, S. J. et al. The log TSH-free T4 relationship in a community-based cohort is nonlinear and is influenced by age, smoking and thyroid peroxidase antibody status. Clin. Endocrinol. (Oxf) 85, 789\u2013796 (2016).","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"25434_CR46","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1056\/NEJMra1901214","volume":"381","author":"HB Burch","year":"2019","unstructured":"Burch, H. B. Drug effects on the thyroid. N. Engl. J. Med. 381, 749\u2013761 (2019).","journal-title":"N. Engl. J. Med."},{"key":"25434_CR47","first-page":"3700","volume":"82","author":"MH Samuels","year":"1997","unstructured":"Samuels, M. H. & McDaniel, P. A. Thyrotropin levels during hydrocortisone infusions that mimic fasting-induced cortisol elevations: A clinical research center study. J. Clin. Endocrinol. Metab. 82, 3700\u20133704 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"25434_CR48","doi-asserted-by":"publisher","first-page":"R255","DOI":"10.1530\/EJE-16-0193","volume":"175","author":"KJ Welsh","year":"2016","unstructured":"Welsh, K. J. & Soldin, S. J. How reliable are free thyroid and total T3 hormone assays?. Eur. J. Endocrinol. 175, R255 (2016).","journal-title":"Eur. J. Endocrinol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25434-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25434-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25434-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T13:05:58Z","timestamp":1763989558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25434-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,24]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25434"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25434-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,11,24]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41542"}}